Abstract
BACKGROUND: Mitral regurgitation (MR) is a frequent complication of end-stage-heart failure. These patients were either managed medically or with mitral valve replacement, both associated with poor outcome. Mitral valve repair with an undersized annuloplasty may improve survival and reduce the need for allografts. METHODS: Forty-one patients with an ejection fraction (EF) 2 underwent mitral valve annuloplasty using the Carpentier physio ring. RESULTS: Thirty day mortality was 12% (n = 5). Seven late mortalities were observed. The use of intra aortic balon pump (IABP) was necessary in seven patients. The 1, 2 and 5 year actuarial survival was 87%, 84% and 57% respectively. CONCLUSIONS: Mitral valve repair is a safe and effective operative intervention that corrects MR and offers a new strategy for patients with MR and end-stage-cardiomyopathy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
